Fairvalue-Calculator Fairvalue-Calculator
EN DE

Thonburi Healthcare Group (THG) Fair Value & Analysis

Healthcare · TH · Market cap 13.5B THB

TH Thonburi Healthcare Group THG · BK
Price7.30 THB
Fair Value1.18 THB
Upside-83.8%
Quality87/100
Evidence: Medium Range 0.8900 THB – 1.48 THB

Fair value as of: Jun 24, 2026

From 24 valuation models · updated 5 days ago

Fair value updated Jun 24, 2026 — revised from 1.58 THB to 1.18 THB (−25.3%) since Jun 23, 2026. Share price −4.5% over the past month.

Price vs Fair Value (12 months)

9.31 THB 6.06 THB Fair Value 1.18 THB Jun 2025 Jun 2026

12‑month range 6.06 THB – 9.31 THB · fair‑value band 0.8900 THB – 1.48 THB · the 7.30 THB price screens above the 1.18 THB fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Thonburi Healthcare Group (THG) currently trades at 7.30 THB, while our model-based Fair Value estimate is 1.18 THB — implying the stock looks roughly 83.8% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, Thonburi Healthcare Group generated revenue of 9.0B THB at a net margin of 1.2%. Revenue declined 3.5% year over year. It earns a return on equity of 1.3%. Net debt stands at 2.9B THB. Fundamentals as of Jun 24, 2026

Key figures & financial health

Revenue (TTM) 9.0B THB
Revenue growth (YoY) -3.5%
Net margin 1.2%
Return on equity 1.3%
Free cash flow 417M THB FY2025
P/E ratio 83.9
More key figures
Operating margin 2.4%
EPS (TTM) 0.0900 THB
Dividend yield 1.9%
EPS growth (YoY) -2.5%
Net debt 2.9B THB FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

About the company

Thonburi Healthcare Group Public Company Limited, together with its subsidiaries, engages in the operation of hospitals in Thailand and Singapore. It operates through six segments: Hospital Operations, Hospital Management, Healthcare Solution Provider, Development and Sales of Hospital Operation Software, Property Development, and Holding. The company offers medical services for various fields, including brain and neurology, bone and joint, gastrointestinal, liver, heart, obstetrics, and gynecology, as well as management services for provincial state hospitals; and operates specialized medical service, step-down care, and hospital heart centers. It also provides senior medical and residence services; distributes medical supplies, devices, and equipment; and retail sales of pharmaceutical and medicinal goods, as well as healthcare products. In addition, the company engages in the development of software for the management of the hospital; development of projects related to health and…

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Thonburi Healthcare Group reported revenue of 9.1B THB in FY2025 versus 10.8B THB in FY2021, a compound −4.3%/yr. Reported net income was 96.2M THB in FY2025, compounding −48.2%/yr from FY2021.

Revenue −4.3%/yr
FY21 10.8B THB
FY22 11.5B THB
FY23 9.8B THB
FY24 9.5B THB
FY25 9.1B THB
Net income −48.2%/yr
FY21 1.3B THB
FY22 1.6B THB
FY23 295M THB
FY24 −1.8B THB
FY25 96.2M THB

Open the full interactive analysis →

Similar stocks

6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc H1CA34 R$95.75 R$123.65 +29%
Fresenius SE FSNUY $11.30 $8.61 -24%
5225 5225 8.67 MYR 3.08 MYR -64%
IHHHF IHHHF $1.71 $0.7400 -57%
Tenet Healthcare Corporation THC $162.06 $282.55 +74%
Rede D'Or São Luiz S.A RDOR3 R$32.76 R$30.33 -7%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Thonburi Healthcare Group (THG) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1.18 THB versus a price of 7.30 THB — about −84% (overvalued). Model-based estimate, not financial advice.
What is the fair value of THG?
Our 21-model fair value for Thonburi Healthcare Group is 1.18 THB (as of Jun 24, 2026), built from audited fundamentals. The current price is 7.30 THB.
What is the quality score of THG?
Thonburi Healthcare Group has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Thonburi Healthcare Group (THG)?
Thonburi Healthcare Group reported trailing-twelve-month revenue of about 9.0B THB (latest available figure, as of Jun 24, 2026).
What is the net profit margin of THG?
The net profit margin of Thonburi Healthcare Group is about 1.2%, meaning it keeps roughly 1.2% of revenue as net income. Based on the latest reported figures.
Does Thonburi Healthcare Group pay a dividend?
Thonburi Healthcare Group currently shows a dividend yield of about 1.87% relative to its recent price (as of Jun 24, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.